{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:22:28Z","timestamp":1740126148067,"version":"3.37.3"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,20]]},"abstract":"<jats:p>Antibiotic use in hidradenitis suppurativa is decreasing, while the use of adalimumab, glucagon-like peptide agonists and spironolactone increased between 2015 and 2021.<\/jats:p>","DOI":"10.1093\/bjd\/ljae155","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T10:30:36Z","timestamp":1712917836000},"page":"142-143","source":"Crossref","is-referenced-by-count":1,"title":["Trends in antibiotic prescriptions for hidradenitis suppurativa from 2015 to 2021"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4216-3479","authenticated-orcid":false,"given":"Mikael","family":"Horissian","sequence":"first","affiliation":[{"name":"Department of Dermatology, Geisinger Medical Center Danville , PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christen","family":"Samaan","sequence":"additional","affiliation":[{"name":"Dermatology, Laser & Vein Specialists of the Carolinas , Charlotte, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Cohrs","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences Penn State College of Medicine Hershey , PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joslyn","family":"Kirby","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Penn State Health Hershey , PA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"2024062015121261900_ljae155-B1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024062015121261900_ljae155-B2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jdv.15332","article-title":"Rates of antibiotic resistance\/sensitivity in bacterial cultures of hidradenitis suppurativa patients","volume":"33","author":"Bettoli","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024062015121261900_ljae155-B3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2024062015121261900_ljae155-B4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bjd.17537","article-title":"British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018","volume":"180","author":"Ingram","year":"2019","journal-title":"Br J Dermatol"},{"key":"2024062015121261900_ljae155-B5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/bjd.21673","article-title":"The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study","volume":"187","author":"Ring","year":"2022","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae155\/57629150\/ljae155.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/191\/1\/142\/58289401\/ljae155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/191\/1\/142\/58289401\/ljae155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:20:22Z","timestamp":1718896822000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/191\/1\/142\/7644475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4,12]]},"published-print":{"date-parts":[[2024,6,20]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae155","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"type":"print","value":"0007-0963"},{"type":"electronic","value":"1365-2133"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,4,12]]}}}